عنوان

Emerging Policy Issues in Synthetic Biology.

شابک

1306934842

شابک

9264208429

شابک

9781306934848

شابک

9789264208421

شماره

b384840

عنوان اصلي

Emerging Policy Issues in Synthetic Biology.

نام عام مواد

[Book]

نام ناشر، پخش کننده و غيره

OECD Publishing,

تاریخ نشرو بخش و غیره

2014.

متن يادداشت

Foreword -- Abbreviations and acronyms -- Executive summary -- Synthetic biology: A new and promising technology -- The applications and potential benefits of synthetic biology -- Research infrastructure challenges for synthetic biology -- Changing investment patterns in synthetic biology -- Intellectual property issues and synthetic biology -- Governance, regulation and risk management in synthetic biology -- National policies for the development and application of synthetic biology.

متن يادداشت

Synthetic biology is at such an early stage of development that there is no uniform agreement as yet about what it actually is. To some, it represents a natural extension of genetic engineering, and therefore is "business as usual". For others, it is a way to bring mass manufacturing out from the decades of biotechnology research. Currently the discipline is limited by the ability to synthesise DNA cost-effectivelySynthetic biology is at such an early stage of development that there is no uniform agreement as yet about what it actually is. To some, it represents a natural extension of genetic engineering, and therefore is "business as usual". For others, it is a way to bring mass manufacturing out from the decades of biotechnology research. Currently the discipline is limited by the ability to synthesise DNA cost-effectivelySynthetic biology is at such an early stage of development that there is no uniform agreement as yet about what it actually is. To some, it represents a natural extension of genetic engineering, and therefore is "business as usual". For others, it is a way to bring mass manufacturing out from the decades of biotechnology research. Currently the discipline is limited by the ability to synthesise DNA cost-effectively",,,,,"Synthetic biology is at such an early stage of development that there is no uniform agreement as yet about what it actually is. To some, it represents a natural extension of genetic engineering, and therefore is "business as usual". For others, it is a way to bring mass manufacturing out from the decades of biotechnology research. Currently the discipline is limited by the ability to synthesise DNA cost-effectively but this is a technical barrier that it is anticipated will be overcome. Synthetic biology raises a number of policy issues around R & D funding, company investment, PPP arrangements and innovative financing, infrastructure requirements, education and training, intellectual property (IP), regulation, and public engagement. In preparation for the continuing development and greater use of synthetic biology, some countries have started to prepare synthetic biology technical roadmaps and a global roadmap for the medium term would be an extremely useful policy tool. Technical roadmaps could both identify likely future policy requirements, and be a useful vehicle in public engagement.

موضوع مستند نشده

Electronic books; Juvenile works; Juvenile literature

مستند نام اشخاص تاييد نشده

OECD OCDE

نام الکترونيکي

نوع ماده

[Book]

تكميل شده

Y